TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global and United States Rotavirus Vaccines Market Report & Forecast 2022-2028

Global and United States Rotavirus Vaccines Market Report & Forecast 2022-2028

  • Category:Life Sciences
  • Published on : 14 September 2022
  • Pages :90
  • Formats:
  • Report Code:SMR-7352482
OfferClick for best price

Best Price: $3480

Rotavirus Vaccines Market Size, Share 2022


Market Analysis and Insights: Global Rotavirus Vaccines Market

The global Rotavirus Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Rotavirus Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Rotavirus Vaccines market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Rotavirus Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Rotavirus Vaccines market.

Global Rotavirus Vaccines Scope and Market Size

Rotavirus Vaccines market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Rotavirus Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Rotavirus Vaccines market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

Rotarix

RotaTeq

Rotavac

Rotavin-M1

Lanzhou lamb

Others

Segment by Application

Adult

Pediatric

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

By Company

Bharat Biotech

Merck & Co., Inc

GlaxoSmithKline plc

Lanzhou Institute of Biological

Bharat Biotech International Limited

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Rotavirus Vaccines product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Rotavirus Vaccines, with price, sales, revenue, and global market share of Rotavirus Vaccines from 2019 to 2022.

Chapter 3, the Rotavirus Vaccines competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Rotavirus Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Rotavirus Vaccines market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Rotavirus Vaccines.

Chapter 13, 14, and 15, to describe Rotavirus Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Rotavirus Vaccines Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global and United States Rotavirus Vaccines Market Report & Forecast 2022-2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 90 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Study Coverage
1.1 Rotavirus Vaccines Product Introduction
1.2 Global Rotavirus Vaccines Outlook 2017 VS 2022 VS 2028
1.2.1 Global Rotavirus Vaccines Sales in US$ Million for the Year 2017-2028
1.2.2 Global Rotavirus Vaccines Sales in Volume for the Year 2017-2028
1.3 United States Rotavirus Vaccines Outlook 2017 VS 2022 VS 2028
1.3.1 United States Rotavirus Vaccines Sales in US$ Million for the Year 2017-2028
1.3.2 United States Rotavirus Vaccines Sales in Volume for the Year 2017-2028
1.4 Rotavirus Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Rotavirus Vaccines in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Rotavirus Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Rotavirus Vaccines Market Dynamics
1.5.1 Rotavirus Vaccines Industry Trends
1.5.2 Rotavirus Vaccines Market Drivers
1.5.3 Rotavirus Vaccines Market Challenges
1.5.4 Rotavirus Vaccines Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Rotavirus Vaccines Market Segment by Type
2.1.1 Rotarix
2.1.2 RotaTeq
2.1.3 Rotavac
2.1.4 Rotavin-M1
2.1.5 Lanzhou lamb
2.1.6 Others
2.2 Global Rotavirus Vaccines Market Size by Type
2.2.1 Global Rotavirus Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Rotavirus Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Rotavirus Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Rotavirus Vaccines Market Size by Type
2.3.1 United States Rotavirus Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Rotavirus Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Rotavirus Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Rotavirus Vaccines Market Segment by Application
3.1.1 Adult
3.1.2 Pediatric
3.2 Global Rotavirus Vaccines Market Size by Application
3.2.1 Global Rotavirus Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Rotavirus Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Rotavirus Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Rotavirus Vaccines Market Size by Application
3.3.1 United States Rotavirus Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Rotavirus Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Rotavirus Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Rotavirus Vaccines Competitor Landscape by Company
4.1 Global Rotavirus Vaccines Market Size by Company
4.1.1 Top Global Rotavirus Vaccines Manufacturers Ranked by Revenue (2021)
4.1.2 Global Rotavirus Vaccines Revenue by Manufacturer (2017-2022)
4.1.3 Global Rotavirus Vaccines Sales by Manufacturer (2017-2022)
4.1.4 Global Rotavirus Vaccines Price by Manufacturer (2017-2022)
4.2 Global Rotavirus Vaccines Concentration Ratio (CR)
4.2.1 Rotavirus Vaccines Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Rotavirus Vaccines in 2021
4.2.3 Global Rotavirus Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Rotavirus Vaccines Manufacturing Base Distribution, Product Type
4.3.1 Global Rotavirus Vaccines Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Rotavirus Vaccines Product Type
4.3.3 Date of International Manufacturers Enter into Rotavirus Vaccines Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Rotavirus Vaccines Market Size by Company
4.5.1 Top Rotavirus Vaccines Players in United States, Ranked by Revenue (2021)
4.5.2 United States Rotavirus Vaccines Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Rotavirus Vaccines Sales by Players (2020, 2021 & 2022)
5 Global Rotavirus Vaccines Market Size by Region
5.1 Global Rotavirus Vaccines Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Rotavirus Vaccines Market Size in Volume by Region (2017-2028)
5.2.1 Global Rotavirus Vaccines Sales in Volume by Region: 2017-2022
5.2.2 Global Rotavirus Vaccines Sales in Volume Forecast by Region (2023-2028)
5.3 Global Rotavirus Vaccines Market Size in Value by Region (2017-2028)
5.3.1 Global Rotavirus Vaccines Sales in Value by Region: 2017-2022
5.3.2 Global Rotavirus Vaccines Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Rotavirus Vaccines Market Size YoY Growth 2017-2028
6.1.2 North America Rotavirus Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Rotavirus Vaccines Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Rotavirus Vaccines Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Rotavirus Vaccines Market Size YoY Growth 2017-2028
6.3.2 Europe Rotavirus Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Rotavirus Vaccines Market Size YoY Growth 2017-2028
6.4.2 Latin America Rotavirus Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Rotavirus Vaccines Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Rotavirus Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Bharat Biotech
7.1.1 Bharat Biotech Corporation Information
7.1.2 Bharat Biotech Description and Business Overview
7.1.3 Bharat Biotech Rotavirus Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Bharat Biotech Rotavirus Vaccines Products Offered
7.1.5 Bharat Biotech Recent Development
7.2 Merck & Co., Inc
7.2.1 Merck & Co., Inc Corporation Information
7.2.2 Merck & Co., Inc Description and Business Overview
7.2.3 Merck & Co., Inc Rotavirus Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Merck & Co., Inc Rotavirus Vaccines Products Offered
7.2.5 Merck & Co., Inc Recent Development
7.3 GlaxoSmithKline plc
7.3.1 GlaxoSmithKline plc Corporation Information
7.3.2 GlaxoSmithKline plc Description and Business Overview
7.3.3 GlaxoSmithKline plc Rotavirus Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.3.4 GlaxoSmithKline plc Rotavirus Vaccines Products Offered
7.3.5 GlaxoSmithKline plc Recent Development
7.4 Lanzhou Institute of Biological
7.4.1 Lanzhou Institute of Biological Corporation Information
7.4.2 Lanzhou Institute of Biological Description and Business Overview
7.4.3 Lanzhou Institute of Biological Rotavirus Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Lanzhou Institute of Biological Rotavirus Vaccines Products Offered
7.4.5 Lanzhou Institute of Biological Recent Development
7.5 Bharat Biotech International Limited
7.5.1 Bharat Biotech International Limited Corporation Information
7.5.2 Bharat Biotech International Limited Description and Business Overview
7.5.3 Bharat Biotech International Limited Rotavirus Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Bharat Biotech International Limited Rotavirus Vaccines Products Offered
7.5.5 Bharat Biotech International Limited Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Rotavirus Vaccines Industry Chain Analysis
8.2 Rotavirus Vaccines Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Rotavirus Vaccines Distributors
8.3 Rotavirus Vaccines Production Mode & Process
8.4 Rotavirus Vaccines Sales and Marketing
8.4.1 Rotavirus Vaccines Sales Channels
8.4.2 Rotavirus Vaccines Distributors
8.5 Rotavirus Vaccines Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Rotavirus Vaccines CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Rotavirus Vaccines Market Trends
Table 3. Rotavirus Vaccines Market Drivers
Table 4. Rotavirus Vaccines Market Challenges
Table 5. Rotavirus Vaccines Market Restraints
Table 6. Global Rotavirus Vaccines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Rotavirus Vaccines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Rotavirus Vaccines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Rotavirus Vaccines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Rotavirus Vaccines Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Rotavirus Vaccines Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Rotavirus Vaccines Revenue Share by Manufacturer, 2017-2022
Table 13. Global Rotavirus Vaccines Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Rotavirus Vaccines Sales Share by Manufacturer, 2017-2022
Table 15. Global Rotavirus Vaccines Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Rotavirus Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Rotavirus Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rotavirus Vaccines as of 2021)
Table 18. Top Players of Rotavirus Vaccines in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Rotavirus Vaccines Product Type
Table 20. Date of International Manufacturers Enter into Rotavirus Vaccines Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Rotavirus Vaccines Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Rotavirus Vaccines Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Rotavirus Vaccines Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Rotavirus Vaccines Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Rotavirus Vaccines Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Rotavirus Vaccines Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Rotavirus Vaccines Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Rotavirus Vaccines Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Rotavirus Vaccines Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Rotavirus Vaccines Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Rotavirus Vaccines Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Rotavirus Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Rotavirus Vaccines Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Rotavirus Vaccines Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Rotavirus Vaccines Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Rotavirus Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Rotavirus Vaccines Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Rotavirus Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Rotavirus Vaccines Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Rotavirus Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Bharat Biotech Corporation Information
Table 43. Bharat Biotech Description and Business Overview
Table 44. Bharat Biotech Rotavirus Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Bharat Biotech Rotavirus Vaccines Product
Table 46. Bharat Biotech Recent Development
Table 47. Merck & Co., Inc Corporation Information
Table 48. Merck & Co., Inc Description and Business Overview
Table 49. Merck & Co., Inc Rotavirus Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Merck & Co., Inc Product
Table 51. Merck & Co., Inc Recent Development
Table 52. GlaxoSmithKline plc Corporation Information
Table 53. GlaxoSmithKline plc Description and Business Overview
Table 54. GlaxoSmithKline plc Rotavirus Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. GlaxoSmithKline plc Product
Table 56. GlaxoSmithKline plc Recent Development
Table 57. Lanzhou Institute of Biological Corporation Information
Table 58. Lanzhou Institute of Biological Description and Business Overview
Table 59. Lanzhou Institute of Biological Rotavirus Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Lanzhou Institute of Biological Product
Table 61. Lanzhou Institute of Biological Recent Development
Table 62. Bharat Biotech International Limited Corporation Information
Table 63. Bharat Biotech International Limited Description and Business Overview
Table 64. Bharat Biotech International Limited Rotavirus Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Bharat Biotech International Limited Product
Table 66. Bharat Biotech International Limited Recent Development
Table 67. Key Raw Materials Lists
Table 68. Raw Materials Key Suppliers Lists
Table 69. Rotavirus Vaccines Customers List
Table 70. Rotavirus Vaccines Distributors List
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Rotavirus Vaccines Product Picture
Figure 2. Global Rotavirus Vaccines Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Rotavirus Vaccines Market Size 2017-2028 (US$ Million)
Figure 4. Global Rotavirus Vaccines Sales 2017-2028 (K Units)
Figure 5. United States Rotavirus Vaccines Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Rotavirus Vaccines Market Size 2017-2028 (US$ Million)
Figure 7. United States Rotavirus Vaccines Sales 2017-2028 (K Units)
Figure 8. United States Rotavirus Vaccines Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Rotavirus Vaccines Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Rotavirus Vaccines Report Years Considered
Figure 11. Product Picture of Rotarix
Figure 12. Product Picture of RotaTeq
Figure 13. Product Picture of Rotavac
Figure 14. Product Picture of Rotavin-M1
Figure 15. Product Picture of Lanzhou lamb
Figure 16. Product Picture of Others
Figure 17. Global Rotavirus Vaccines Market Share by Type in 2022 & 2028
Figure 18. Global Rotavirus Vaccines Sales in Value by Type (2017-2028) & (US$ Million)
Figure 19. Global Rotavirus Vaccines Sales Market Share in Value by Type (2017-2028)
Figure 20. Global Rotavirus Vaccines Sales by Type (2017-2028) & (K Units)
Figure 21. Global Rotavirus Vaccines Sales Market Share in Volume by Type (2017-2028)
Figure 22. Global Rotavirus Vaccines Price by Type (2017-2028) & (USD/Unit)
Figure 23. United States Rotavirus Vaccines Market Share by Type in 2022 & 2028
Figure 24. United States Rotavirus Vaccines Sales in Value by Type (2017-2028) & (US$ Million)
Figure 25. United States Rotavirus Vaccines Sales Market Share in Value by Type (2017-2028)
Figure 26. United States Rotavirus Vaccines Sales by Type (2017-2028) & (K Units)
Figure 27. United States Rotavirus Vaccines Sales Market Share in Volume by Type (2017-2028)
Figure 28. United States Rotavirus Vaccines Price by Type (2017-2028) & (USD/Unit)
Figure 29. Product Picture of Adult
Figure 30. Product Picture of Pediatric
Figure 31. Global Rotavirus Vaccines Market Share by Application in 2022 & 2028
Figure 32. Global Rotavirus Vaccines Sales in Value by Application (2017-2028) & (US$ Million)
Figure 33. Global Rotavirus Vaccines Sales Market Share in Value by Application (2017-2028)
Figure 34. Global Rotavirus Vaccines Sales by Application (2017-2028) & (K Units)
Figure 35. Global Rotavirus Vaccines Sales Market Share in Volume by Application (2017-2028)
Figure 36. Global Rotavirus Vaccines Price by Application (2017-2028) & (USD/Unit)
Figure 37. United States Rotavirus Vaccines Market Share by Application in 2022 & 2028
Figure 38. United States Rotavirus Vaccines Sales in Value by Application (2017-2028) & (US$ Million)
Figure 39. United States Rotavirus Vaccines Sales Market Share in Value by Application (2017-2028)
Figure 40. United States Rotavirus Vaccines Sales by Application (2017-2028) & (K Units)
Figure 41. United States Rotavirus Vaccines Sales Market Share in Volume by Application (2017-2028)
Figure 42. United States Rotavirus Vaccines Price by Application (2017-2028) & (USD/Unit)
Figure 43. North America Rotavirus Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 44. North America Rotavirus Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 45. U.S. Rotavirus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Canada Rotavirus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. Europe Rotavirus Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 48. Europe Rotavirus Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 49. Germany Rotavirus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. France Rotavirus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. U.K. Rotavirus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Italy Rotavirus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Russia Rotavirus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Asia-Pacific Rotavirus Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 55. Asia-Pacific Rotavirus Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 56. China Rotavirus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Japan Rotavirus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. South Korea Rotavirus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. India Rotavirus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Australia Rotavirus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Taiwan Rotavirus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Indonesia Rotavirus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Thailand Rotavirus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Malaysia Rotavirus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Philippines Rotavirus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Latin America Rotavirus Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 67. Latin America Rotavirus Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 68. Mexico Rotavirus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Brazil Rotavirus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Argentina Rotavirus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Middle East & Africa Rotavirus Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 72. Middle East & Africa Rotavirus Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 73. Turkey Rotavirus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Saudi Arabia Rotavirus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. UAE Rotavirus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 76. Rotavirus Vaccines Value Chain
Figure 77. Rotavirus Vaccines Production Process
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount